ZIM LABORATORIES
|
The Current P/E Ratio of ZIM LABORATORIES is 349.18.
| Share Price | ₹134.6 | Nov 04,2026 |
| Market Cap | ₹722.8 Cr | |
| Earnings-TTM | ₹2.1 Cr | TTM-Consolidated Results |
| Price/Earnings | 349.18x | Calculated as Market Cap/Earnings |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PE (Price/Earnings) ratio of ZIM LABORATORIES
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹722.8 Cr] as on Nov 04,2026
(/) Earnings [ ₹2.1 Cr] based on TTM-Consolidated Results
(=) P/E Ratio [ 349.18x ]
Thus, for ZIM LABORATORIES , the investors are currently willing to pay 349.18 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of ZIM LABORATORIES !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of ZIM LABORATORIES over the last five years.
Historical PE (Price/Earnings) ratio chart of ZIM LABORATORIES
PE Ratio Performance Analysis for ZIM LABORATORIES
- ZIM LABORATORIES 's p/e ratio for fiscal years ending Mar2026 to Mar2022 averaged 26.87x.
- ZIM LABORATORIES 's operated at median p/e ratio of 26.98x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, ZIM LABORATORIES 's p/e ratio peaked in Mar2026 at 54.87x.
- ZIM LABORATORIES 's p/e ratio hit its five-year low in Mar2022 of 5.95x.
How does ZIM LABORATORIES 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
|---|---|---|---|
| ZIM LABORATORIES | 2.07 | 349.18 | 722.8 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 11,037.20 | 38.61 | 426,122.0 |
| DIVIS LABORATORIES LTD | 2,925.00 | 91.09 | 266,424.0 |
| TORRENT PHARMACEUTICALS LTD | 2,099.00 | 85.71 | 179,914.0 |
| CIPLA LTD | 2,868.29 | 39.44 | 113,112.0 |
| DR REDDYS LABORATORIES LTD | 2,759.70 | 41.53 | 114,599.0 |
| MANKIND PHARMA LTD | 2,249.69 | 46.51 | 104,631.0 |
| LUPIN LTD | 5,221.47 | 17.65 | 92,144.5 |
| ZYDUS LIFESCIENCES LTD | 4,159.00 | 28.54 | 118,703.0 |
| AUROBINDO PHARMA LTD | 3,712.74 | 26.36 | 97,877.5 |
| LAURUS LABS LTD | 1,333.75 | 93.42 | 124,601.0 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs ZIM LABORATORIES 's P/E Ratio
| Top 10 Industry Peers | PE Ratio |
|---|---|
| Min industry PE | 17.65x |
| Max industry PE | 349.18x |
| Median industry PE | 41.53x |
| Average industry PE | 78.00x |
You may also like the below Video Courses